TGIF2 and central nervous system cancer: Co‐transfection of anti‐miR‐129‐5p rescued the expression level of TGIF2. CCK‐8 results demonstrated that the viability of glioma cell was remarkably stronger in TGIF2 overexpression group while was notably weaker in TGIF2 knockdown group in comparison with the mock group (P < .05, Figure 6B,C).